Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2015-06-26

First treatment recommended for rare bone disease

View source ↗

Summary

EMA recommends the first treatment for a rare bone disease, marking a pivotal step toward an approved therapy for the condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications